DrugPatentWatch Database Preview
Litigation Details for Professional Drug Company, Inc. v. Wyeth, Inc. (S.D. Miss. 2011)
» See Plans and Pricing
Professional Drug Company, Inc. v. Wyeth, Inc. (S.D. Miss. 2011)
| Docket | Start Trial | Date Filed | 2011-05-02 |
| Court | District Court, S.D. Mississippi | Date Terminated | 2011-09-21 |
| Cause | 15:2 Antitrust Litigation | Assigned To | Louis Guirola Jr. |
| Jury Demand | Plaintiff | Referred To | Robert H. Walker |
| Patents | 6,274,171; 6,403,120; 6,419,958 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Professional Drug Company, Inc. v. Wyeth, Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , and Start Trial .
Details for Professional Drug Company, Inc. v. Wyeth, Inc. (S.D. Miss. 2011)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2011-05-02 | 1 | Application issued as U.S. Patent No. 6,274,171 Bl (“ ‘ 171 patent”). The ‘ 171 patent contains 25 claims in…method of use patents: the ‘171 patent, the ‘958 patent, and the ‘ 120 patent. These three patents ostensibly…Edgren patent qualifies as patent defeating prior art against the method of use patents as a patent application…despite knowing (i) an earlier Wyeth patent (the Upton patent) and a patent application by a Wyeth collaborator…three method of use patents, the ‘ 171, ‘958, and ‘ 120 patents All three patents are, and have always | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
